CCL21 and neoplasm: In vivo studies revealed that metastatic tumor formation is decreased when CCL21 expression is knocked down in secondary lymphoid organs, since this diminishes both the chemotactic and antiapoptotic effects of CCR7-expressing tumor cells [14].